Zafirlukast has also been reported to prevent tamoxifen-induced oxidative stress and inflammation [27] and TNF-αinduced endothelial inflammation [28]; Bromocriptine has been reported to be used for glycemic control in patients with type 2 diabetes mellitus [29]. Here, TNF is linked to type 2 diabetes mellitus.